NACIONALINIS OSTEOPOROZĖS CENTRAS, VšĮ - financials and debts
Company age: 28 y. 2 mo.
NACIONALINIS OSTEOPOROZĖS CENTRAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 72,004 | 35,214 | 53,904 | 82,253 | 114,969 | 89,226 | 67,776 |
| Profit before tax | - | - | - | - | -12,860 | -1,523 | -42,217 | -43,030 |
| Net profit | - | - | - | - | -12,860 | -1,523 | -42,217 | -43,030 |
| Equity | 14,806 | -368 | -22,878 | -161,296 | -174,156 | -175,679 | -288,898 | -331,928 |
| Liabilities | 81,617 | 94,283 | 97,815 | 245,781 | 281,056 | 315,950 | 376,019 | 409,294 |
| Non-current assets | 29,759 | 52,491 | 52,491 | 55,041 | 54,191 | 53,341 | 52,491 | 52,622 |
| Current assets | 66,664 | 41,424 | 22,446 | 29,444 | 52,709 | 86,930 | 34,630 | 24,744 |
| Total assets | 96,423 | 93,915 | 74,937 | 84,485 | 106,900 | 140,271 | 87,121 | 77,366 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 12,443 | 15,609 | 13,157 |
| Social insurance contributions | - | - | - | - | - | 9,500 | 10,866 | 9,870 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | -51.1% | +53.1% | +52.6% | +39.8% | -22.4% | -24.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | -12.0% | -1.1% | -48.5% | -55.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | -15.6% | -1.3% | -47.3% | -63.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | -15.6% | -1.3% | -47.3% | -63.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 5.5 | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 5,685 | 3,201 | 4,900 | 7,478 | 11,402 | 8,498 | 7,072 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
NACIONALINIS OSTEOPOROZĖS CENTRAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-20 | 221.70 |
| 2026-07-16 | 2026-07-17 | 221.70 |
| 2025-08-28 | 2025-08-29 | 1.09 |
| 2025-08-19 | 2025-08-25 | 1.09 |
| 2025-08-13 | 2025-08-13 | 1.09 |
| 2025-07-24 | 2025-08-12 | 1.96 |
| 2025-07-16 | 2025-07-23 | 0.87 |
| 2025-06-18 | 2025-07-13 | 0.87 |
| 2025-06-11 | 2025-06-12 | 0.87 |
| 2025-06-08 | 2025-06-09 | 0.87 |
| 2025-05-21 | 2025-06-04 | 0.87 |
| 2025-05-16 | 2025-05-20 | 115.92 |
| 2025-05-04 | 2025-05-13 | 115.92 |
| 2025-05-01 | 2025-05-01 | 115.92 |
| 2025-04-30 | 2025-04-30 | 115.05 |
| 2025-04-24 | 2025-04-29 | 115.92 |
| 2025-04-16 | 2025-04-23 | 115.05 |
| 2025-04-04 | 2025-04-13 | 115.05 |
NACIONALINIS OSTEOPOROZĖS CENTRAS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-09-12 | 2025-09-12 | 75.37 |
| 2025-08-14 | 2025-08-14 | 74.79 |
| 2025-07-08 | 2025-07-20 | 74.25 |
| 2025-04-16 | 2025-04-16 | 74.77 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
NACIONALINIS OSTEOPOROZES CENTRAS, VšI (code 124541289) is a Public Institution operating in medical specialists activities. In the latest financial year 2025, revenue amounted to €67.8K, down 24.0% year on year and 41.0% versus 2023. The company reported a net loss of €43.0K, with a profit margin of -63.5%, showing a materially weaker result than in 2024 and 2023, when losses were €42.2K and €1.5K respectively. Over the three-year period, revenue declined steadily from €115.0K in 2023 to €89.2K in 2024 and €67.8K in 2025, while losses widened sharply after 2023. Balance sheet figures also softened: total assets fell from €140.3K in 2023 to €87.1K in 2024 and €77.4K in 2025. Equity remained negative and deteriorated to -€331.9K in 2025, while liabilities increased to €409.3K. Long-term assets stayed broadly stable at about €52.5K-€53.3K, while short-term assets declined. Revenue per employee was €7.5K in 2025.